| Harland, Deborah (GSK 200904 Partner at SR One Ltd) |
Partner (venture partner) |
SR One (Group) |
United States (USA) |
| Harmeier, Anja (Rewind Therapeutics 202301 CEO + Bellevue 202007 Partner at Pureos Bioventures) |
Chief Executive Officer (CEO) |
Rewind Therapeutics N.V. |
Belgium |
| Harms, Carsten |
n. a. |
Eurofins (Group) |
Germany |
| Harmsen, Dag (Ridom GmbH 201307 Managing Director) |
Managing Director |
Ridom GmbH |
Germany |
| Harnest, Simon (Metagenomi 202107– Chief Investment Officer + SVP Strategy before Cellectis + Trout Group) |
Public Relations Manager / Investor Relations Manager |
Metagenomi Inc. |
United States (USA) |
| Harold, Theodora (Crescendo Biologics 201905– CEO before CFO before PsiOxus + Mission Tx + OrthoMimectics + Cytomax) |
Chief Executive Officer (CEO) |
Crescendo Biologics Ltd. |
United Kingdom (GB) |
| Harper, Sean E. (Amgen 201307 EVP RnD) |
Research & Development Manager |
Amgen (Group) |
United States (USA) |
| Harr, Steve (Sana Biotechnology 201901– CEO before Juno Therapeutics 201509 CFO + Head Corporate Development) |
Chief Executive Officer (CEO) |
Sana Biotechnology Inc. |
United States (USA) |
| Harrington-Smith, Kristen (ADC Therapeutics 202211– CCO before Immunogen + Novartis Pharmaceuticals) |
Chief Commercial Officer (CCO) |
ADC Therapeutics (Group) |
Switzerland |
| Harris, Michael (Sigma-Aldrich 201104 VP Managing Director EMEA) |
Regional manager |
Merck (DE) (Group) |
Switzerland |
| Harrison, Clark (Biocartis 201201– COO before Leica Biosystems VP Global Operations) |
Chief Operating Officer (COO) |
Biocartis (Group) |
Switzerland |
| Harrison, Tim (Almac 201506 VP Drug Discovery at Almac Discovery) |
Research & Development Manager |
Almac (Group) |
United Kingdom (GB) |
| Hart, Bradley (Thermo Fisher 201509 Strategic Director Life Sciences MS Clinical Markets) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Hart, Richard C. (Qiagen 201009 Director Human Resources Qiagen US) |
Human Resources Manager |
Qiagen (Group) |
United States (USA) |
| Hartel, Christian (Wacker 202206 CEO) |
Chief Executive Officer (CEO) |
Wacker (Group) |
Germany |
| Hartert, Daniel (Bayer 201711 Chief Information Officer) |
Chief Information Officer (CIO) / Chief Digital Officer |
Bayer (Group) |
Germany |
| Hartl, Franz-Ulrich (Max Planck 200909 Director MPI for Biochemistry Munich) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Hartman, Brad (Be Biopharma 202208– Chief People Officer before FerGene + ConnectedSearch) |
Human Resources Manager |
Be Biopharma Inc. |
United States (USA) |
| Hartmann, Andreas (Greenovation Biotech 201405– CBO before Therabel + Emergent BioSolutions + Bavarian Nordic) |
Chief Business Officer (CBO) |
Eleva GmbH |
Germany |
| Hartmann, Gunther (Univ Hospital Bonn 201503 Professor + Co-founder + Board Chairman of Rigontec GmbH) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Hartmann, Hans Bodo (greenovation 200606 Managing Director) |
Managing Director |
Eleva GmbH |
Germany |
| Hartmann, Kai (Definiens 201305 Director Product Marketing Life Sciences) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
Germany |
| Hartmann, Ute (Brandenburg (govt) 201204 Life Science team leader at Brandenburg Economic Development Board) |
Business Development Manager / Strategy Manager |
Brandenburg (govt region) |
Germany |
| Hartung, Matthias (Semalytix 202308 Managing Director + CRDO + Co-Founder) |
Managing Director |
Semalytix GmbH |
Germany |
| Hartwig, Gabriele (Sacura GmbH 201201– Managing Director before Amantec GmbH Managing Director) |
Managing Director |
Sacura GmbH |
Germany |
| Hartwig, Wolfgang (Bayer) |
n. a. |
Bayer (Group) |
Germany |
| Harvey, Lucy (QuantuMDx 201506 Business Development + Marketing Officer) |
Business Development Manager / Strategy Manager |
QuantuMDx (Group) |
United Kingdom (GB) |
| Hasan, Rafiq (Complement Therapeutics 202202– CEO before Exact Therapeutics + Bayer + Novartis) |
Chief Executive Officer (CEO) |
Complement Therapeutics (CTx) (Group) |
United Kingdom (GB) |
| Haselhuhn, Rafael (Omnilab (DE) 201511 Managing Director + Minority Owner of Opti-Lab GmbH) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Haselsteiner, Klemens (STRABAG 202310 CEO) |
Chief Executive Officer (CEO) |
STRABAG (Group) |
Austria |
| Hasenmaier, Joachim (Boehringer 201210– Managing Director responsible for Consumer Healthcare + Animal Health) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
| Hashemi, Brian B. (Novigenix 202211 CEO + Executive Chairman) |
Chief Executive Officer (CEO) |
Novigenix S.A. |
Switzerland |
| Hashimoto, Lara (Sophia Genetics 202004– CBO before Roche Diagnostics) |
Chief Business Officer (CBO) |
Sophia Genetics (Group) |
Switzerland |
| Hasler, Hans Peter (Élan 201210– COO before HBM Bioventures + HPH Management before Biogen Idec COO) |
Chief Operating Officer (COO) |
Élan (Group) |
Ireland, Republic of |
| Hassabis, Demis (Alphabet 202107 CEO + Co-Founder of DeepMind) |
Chief Executive Officer (CEO) |
Alphabet (formerly Google) (Group) |
United Kingdom (GB) |
| Hassan, Tolga (AgomAb Therapeutics 202103– CFO before F-Star + Johnson Matthey) |
Chief Financial Officer (CFO) |
Agomab Therapeutics (Group) |
Belgium |
| Hasselmann, Harald (Eckert & Ziegler 202306– promoted to Executive Director & Board Chair) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Hasskarl, Horst |
n. a. |
AbbVie (Group) |
Germany |
| Hassler, Werner (Biotrend / Anawa Trading 201204 CEO) |
Chief Executive Officer (CEO) |
Biotrend (Group) |
Switzerland |
| Hastie, Rohan (Metabolon 201806– CEO joined 201709 as CBO before Arrow Life Sciences & Healthcare + Hologic) |
Chief Executive Officer (CEO) |
Metabolon (Group) |
United States (USA) |
| Hatano, Isao (Merck (DE) 202212 Head of Process Solutions at Merck Life Science business sector in Japan) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Hatchett, Richard (CEPI 201902 CEO) |
Chief Executive Officer (CEO) |
Coalition for Epidemic Preparedness Innovations (CEPI) |
Norway |
| Hattermann, Stefanie |
n. a. |
Omnilab (DE) (Group) |
Germany |
| Hatz, Benedikte (TeGenero 200603 CEO) |
Chief Executive Officer (CEO) |
TeGenero AG |
Germany |
| Haubner, Ralph (Axaron 200307– CFO before Boehringer Ingelheim + GD Searle + Fresenius + Biotest) |
Chief Financial Officer (CFO) |
2invest (Group) |
Germany |
| Haubner, Simone (Biosaxony 202207 Project Management Medical Technology) |
Business Development Manager / Strategy Manager |
Biosaxony Management GmbH |
Germany |
| Hauck, Gerrit (Basilea 201807– CTO before Sanofi) |
Chief Technology/Technical Officer (CTO) |
Basilea (Group) |
Switzerland |
| Hauck, Sabine (Leukocare 201904 VP RnD) |
Research & Development Manager |
Leukocare (Group) |
Germany |
| Hauck, Simone (Eppendorf 202104– Manager Coprorate Communications before Life Science Nord) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
| Hauck, Stefanie (Helmholtz 201202 Deputy Head Research Unit Protein Science at Helmholtz-Zentrum München) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hauer, Andreas (Savira Pharmaceuticals 201210– CFO before Erste Group Bank + Igeneon) |
Chief Financial Officer (CFO) |
Savira Pharmaceuticals GmbH |
Austria |
| Hauffe, Dietrich (Bruker 201508– EVP Life Sciences Mass Spectrometry at Bruker Daltonics before Qiagen + Dionex) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Haug, Matthias (Bayer 201206 Head of Seed Treatment at Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Haug, Peter (Oncgnostics GmbH 201501 Business Development + Licensing Manager) |
Business Development Manager / Strategy Manager |
Oncgnostics GmbH |
Germany |
| Hauge, Elise (Lundbeck 201909– EVP People + Communication before SimCorp + Takeda + Nycomed) |
Human Resources Manager |
Lundbeck (Group) |
Denmark |
| Haugg, Norbert |
n. a. |
Deutsches Patent- und Markenamt |
Germany |
| Hauke, Sven (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech) |
Managing Director |
ZytoVision (Group) |
Germany |
| Hauner, Anna (Temedica 202308 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Temedica GmbH |
Germany |
| Haunhorst, Eberhard (Niedersachsen (govt) 201407 President of LAVES) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Haupt, Joachim (PharmAI 202204 CEO) |
Chief Executive Officer (CEO) |
PharmAI GmbH |
Germany |
| Haupt, Lena (Hessen (govt) 201411 Project Manager Life Sciences at Hessen Trade & Invest) |
Cluster Manager |
Hessen (Hesse) (govt region) |
Germany |
| Haupter, Ralph (Microsoft 202303 President of Microsoft EMEA) |
President/Director/Head Business Group/Unit/Division |
Microsoft (Group) |
United States (USA) |
| Hauptmann, Andrea (Minapharm 202004 VP Finance + Administration at ProBioGen AG) |
Financial Manager (CFO, Financial Director, etc.) |
Minapharm (Group) |
Germany |
| Haupts, Ulrich (Coral BioNet 201109– CSO of Scil Proteins GmbH before Bayer + Direvo Biotech + SKB UK) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
UV-Cap (Vetter family office) (Group) |
Germany |
| Haurum, John (F-Star 201205–201810 CEO before ImClone System + Symphogen LEFT 10/18) |
Chief Executive Officer (CEO) |
Sino Biopharm (Group) |
United Kingdom (GB) |
| Hausch, Marcus |
n. a. |
febit (Group) |
Germany |
| Hausdorf, Gabriele (Germany (govt) 201005 BMBF) |
Governmental Officer / Adminstrative Officer |
Germany (govt) |
Germany |
| Haustedt, Lars Ole (BRAIN Biotech 202202 VP Projects + Innovtion at Analyticon Discovery) |
n. a. |
BRAIN Biotech (Group) |
Germany |
| Havey, Adam (Emergent BioSolutions 201412 EVP + President Biodefense division) |
President/Director/Head Business Group/Unit/Division |
Emergent BioSolutions (Group) |
United States (USA) |
| Havlina, Roxana (Rovalab 201104 Managing Director) |
Managing Director |
Rovalab GmbH |
Germany |
| Hawa, Gerhard Hawa (Fianostics GmbH 201510 CEO) |
Chief Executive Officer (CEO) |
Fianostics GmbH |
Austria |
| Hawkins, Rick (Lumos Pharma 201604 CEO) |
Chief Executive Officer (CEO) |
Lumos Pharma (US) |
United States (USA) |
| Hawkins, Tim (Schauenburg 201308– Finance Director at Markes Intl before PriceWaterhouseCoopers) |
Chief Financial Officer (CFO) |
Schauenburg (Group) |
United Kingdom (GB) |
| Hawkins, Trevor (ProGenTech 200810 Chairman + CEO) |
Chief Executive Officer (CEO) |
ProGenTech (Group) |
United States (USA) |
| Hayday, Adrian (Professor + Co-Founder of ImmunoQure) |
n. a. |
ImmunoQure (Group) |
Germany |
| Hayden, Michael R. (Forbion 202203– Venture Partner + Prilenia Therapeutics 202006– CEO former CSO at Teva) |
Venture Partner |
Forbion (Group) |
Netherlands |
| Hays, Anne (Lonza 201412 Head Custom Development Services Organisation) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Switzerland |
| Hayward, Colin (Myriad 201501 European Medical Director) |
n. a. |
Myriad Genetics (Group) |
United States (USA) |
| Hazenberg, Wil (BioGeneration Ventures 201112 Partner) |
Partner (venture partner) |
BioGeneration Ventures B.V. (BGV) |
Netherlands |
| Hazlewood, Matt (Thermo Fisher 202003 Senior Director Global Chromatography Data Systems) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| He, Sylvia Xin (Hyfinity Investments 201912 Managing Partner) |
Managing Partner |
Hyfinity Investments (CN) |
China |
| Headly, Martin S. (Brooks Automation –201309 CFO LEFT 9/13) |
Chief Financial Officer (CFO) |
Azenta (Group) |
United States (USA) |
| Healey, Joseph R.J. (Joe) (NanoSyrinx 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NanoSyrinx Ltd. |
United Kingdom (GB) |
| Healy, James I. (Jim) (Sofinnova Ventures 200701 General Partner) |
General Partner (venture partner) |
Sofinnova (Group) |
United States (USA) |
| Heard, Edith (EMBL 202107 Director General) |
President/Director/Head of Research Organisation/Unit |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Hecht, Frank (CellGenix 201702 VP Marketing + Sales) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
| Hecht, Peter (Oridis Biomed 200502– CEO before Tripos) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Austria |
| Hecht, Robert (Olympus 200812 Managing Director Olympus Diagnostics Europe) |
Managing Director |
Olympus (Group) |
Germany |
| Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman) |
Board member, non-executive |
Athenex (Group) |
Switzerland |
| Heck, Albert J. R. (Univ Utrecht 199809– Prof + Head Biomolecular Mass Spec & Proteomics Group) |
Professor |
University of Utrecht (Utrecht University) |
Netherlands |
| Hecker, Michael (Univ Greifswald 201312 Professor) |
Professor |
University of Greifswald |
Germany |
| Heckl, Wolfang M. (LMU München 200505) |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Heckle, Sven (Börse Inside 200511) |
n. a. |
Börse Inside AG |
Germany |
| Hedegaard, Anders (Bavarian Nordic 200708– CEO) |
Chief Executive Officer (CEO) |
Bavarian Nordic (Group) |
Denmark |
| Hediard, Florent (SGS 201610 Life Sciences Marketing Director Agriculture + Food + Life) |
Sales Manager / Marketing Manager |
SGS (Group) |
Switzerland |
| Hédou, Gaël (Relief Therapeutics 201610 COO) |
Chief Operating Officer (COO) |
Relief Therapeutics (Group) |
Switzerland |
| Heeger, Steffen (Selvita 201802– CMO before MorphoSys 201312– Head of Clinical Research before Merck Serono) |
Chief Medical Officer (CMO) |
Selvita (Group) |
Poland |
| Heeren, Ron M. A. (Maastricht Univ 2015 Co-Director of M4I Institute before FOM Amsterdam 200808) |
Professor |
Maastricht University (Universiteit Maastricht, UM) |
Netherlands |
| Heffernan, Michael (Mike) (Avenge Bio 202201 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Avenge Bio Inc. |
United States (USA) |
| Hegendörfer, Thomas (Max Planck 201104 Head Business Development of Lead Discovery Center GmbH) |
Business Development Manager / Strategy Manager |
Max Planck Society for the Advancement of Science |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 29 30 31 ... 88 89 90 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
